Table 1.
Most relevant basal hormonal determinations throughout the patient’s follow-up.
| Mar 2003 | Aug 2005 | Mar 2006 | Nov 2006 | Jun 2007 | Sep 2007 | May 2008 | Jun 2018 | Normal range | |
|---|---|---|---|---|---|---|---|---|---|
| TSH (mU/L) | 1.6 | 0.18 | 0.09 | 0.055 | 0.041 | 2.74 | 0.02 | 0.01 | 0.34–5.6 |
| Free T4 (ng/dL) | 1.00 | 0.60 | 0.53 | 0.62 | 0.40 | 1.48 | 1.19 | 0.6–1.6 | |
| Total T3 (ng/dL) | 149.07 | 97.72 | 80–200 | ||||||
| Serum cortisol (µg/dL) | 17.7 | 9.73 | 1.56 | 6.7–2.6 | |||||
| ACTH (pg/mL) | 1.9 | 10.0–65 | |||||||
| FSH (mU/mL) | 16.4 | 2.51 | 44.28 | * | |||||
| LH (mU/mL) | 3.0 | 2.27 | 21.19 | * | |||||
| Estradiol (pg/mL) | 49.7 | 161 | * | ||||||
| Prolactin (ng/mL) | 8.9 | 9.88 | 3.3–26.7 | ||||||
| IGF-1 (ng/mL) | 105 | 65 | 106.3 | 73–287 |
*Variable according to the phase of the menstrual cycle.
This work is licensed under a